|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA. |
| 公司地址
| 2 International Plaza Drive, Suite 510, Nashville, TN, USA, 37217 |
| 電話號碼
| +1 615 255-8880 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.imdxinc.com |
| 員工數量
| 58 |
| Ms. Andrea James |
Chief Financial Officer |
美元 367.36K |
30/04/2026 |
| Mr. Joshua Riggs |
Director, President and Chief Executive Officer |
美元 472.29K |
30/04/2026 |
| Mr. James Liu |
Vice President, Accounting, Controller, Treasurer and Principal Accounting Officer |
美元 221.80K |
30/04/2026 |
|
|
| Dr. Andrew J. Last, PhD |
Independent Director |
30/04/2026 |
| Mr. Louis E. Silverman |
Independent Director |
30/04/2026 |
| Mr. Joshua Riggs |
Director, President and Chief Executive Officer |
30/04/2026 |
| Mr. Andrew Arno |
Chairman of the Board |
30/04/2026 |
|
|
|
|
